Table 3.
Number of MoAb reactive in benign prostate hyperplasia and prostate cancer (%)
| Number of monoclonal antibodies | |||
|---|---|---|---|
| 1 | 2 | 3 | 4 |
| 6.7 | 73.3 | 6.7 | 13.3 |
| - | 26.7 | 60 | 13.3 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.